Contributions to Oncology - New Drugs in Oncology
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By S. Karger AG

9783805550475, 9783318034202

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Results of a Multicenter Trial in the Treatment of Advanced Renal Cell Carcinoma with a Combination of Recombinant Interferon Alpha-2 a and Vinblastine

Contributions to Oncology - New Drugs in Oncology ◽

10.1159/000417999 ◽

1989 ◽

pp. 292-299

Author(s):

D. Schuster ◽

G. Schneider ◽

N. Ade ◽

M. E. Heim

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Interferon Alpha ◽

Renal Cell ◽

Multicenter Trial ◽

Advanced Renal Cell Carcinoma ◽

Recombinant Interferon ◽

Recombinant Interferon Alpha

Download Full-text

Immunomodulating Activity of Rubratin. Results of a Phase II Trial in Advanced Lung Cancer

Contributions to Oncology - New Drugs in Oncology ◽

10.1159/000417997 ◽

1989 ◽

pp. 279-286 ◽

Cited By ~ 2

Author(s):

P. Drings ◽

H. G. Manke ◽

I. Günther ◽

P. Aulenbacher ◽

M. Peukert

Keyword(s):

Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Lung Cancer ◽

Immunomodulating Activity

Download Full-text

Experience with the Polyelectrolyte Carbetimer in Early Clinical Trials1

Contributions to Oncology - New Drugs in Oncology ◽

10.1159/000417960 ◽

1989 ◽

pp. 12-19

Author(s):

M. Fromm ◽

W. E. Berdel ◽

H. D. Schick ◽

S. Danhauser-Riedl ◽

U. Fink ◽

...

Download Full-text

Trimetrexate: An Update of Recent Basic and Clinical Results

Contributions to Oncology - New Drugs in Oncology ◽

10.1159/000417986 ◽

1989 ◽

pp. 201-206

Author(s):

R. C. Jackson ◽

M. B. Meyer

Keyword(s):

Clinical Results

Download Full-text

Subject Index

Contributions to Oncology - New Drugs in Oncology ◽

10.1159/000418000 ◽

1989 ◽

pp. 300-302

Download Full-text

In vivo Modulation of the Immune System by Mafosfamide in Patients with Advanced Renal Cell Carcinoma. A Phase I Trial

Contributions to Oncology - New Drugs in Oncology ◽

10.1159/000417993 ◽

1989 ◽

pp. 255-258

Author(s):

H. O. Klein ◽

C. Coerper ◽

P. Voigt ◽

G. Golbach

Keyword(s):

Renal Cell Carcinoma ◽

Immune System ◽

Phase I ◽

Cell Carcinoma ◽

Renal Cell ◽

Phase I Trial ◽

Advanced Renal Cell Carcinoma

Download Full-text

Treatment of Patients with Chronic Lymphocytic Leukemia and Non-Hodgkin’s Lymphoma of Low-Grade Malignancy with 1,2,4-Triglycidylurazol

Contributions to Oncology - New Drugs in Oncology ◽

10.1159/000417988 ◽

1989 ◽

pp. 213-218

Author(s):

K. Rieche ◽

R. Donhuijsen-Ant ◽

K. Bremer ◽

H. Link ◽

W. E. Berdel ◽

...

Keyword(s):

Chronic Lymphocytic Leukemia ◽

Hodgkin’S Lymphoma ◽

Lymphocytic Leukemia ◽

Hodgkin's Lymphoma ◽

Low Grade ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Grade Malignancy

Download Full-text

Intensive-Dose Epirubicin with and without High-Dose Verapamil: Toxicity, Pharmacokinetics, Metabolism and Response in Pretreated Patients with Metastatic Breast Cancer

Contributions to Oncology - New Drugs in Oncology ◽

10.1159/000417978 ◽

1989 ◽

pp. 141-151

Author(s):

K. Mross ◽

T. Langenbuch ◽

K. Burk ◽

W. Jonat ◽

D. K. Hossfeld

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

High Dose ◽

Pretreated Patients

Download Full-text

Phase II Study of High-Dose Epirubicin in Non-Small Cell Lung Cancer

Contributions to Oncology - New Drugs in Oncology ◽

10.1159/000417977 ◽

1989 ◽

pp. 136-140 ◽

Cited By ~ 3

Author(s):

H. Henss ◽

H. H. Fiebig ◽

E. E. Holdener ◽

E. Kaplan

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

High Dose ◽

Small Cell Lung

Download Full-text

Phase II Study of Pirarubicin in Small Cell Lung Carcinoma

Contributions to Oncology - New Drugs in Oncology ◽

10.1159/000417973 ◽

1989 ◽

pp. 114-118 ◽

Cited By ~ 2

Author(s):

H. Henss ◽

H. Arnold ◽

H. H. Fiebig ◽

G. W. Löhr

Keyword(s):

Phase Ii ◽

Lung Carcinoma ◽

Phase Ii Study ◽

Small Cell Lung Carcinoma ◽

Small Cell ◽

Small Cell Lung ◽

Cell Lung Carcinoma

Download Full-text

Contributions to Oncology - New Drugs in OncologyLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By S. Karger AG

Results of a Multicenter Trial in the Treatment of Advanced Renal Cell Carcinoma with a Combination of Recombinant Interferon Alpha-2 a and Vinblastine

Immunomodulating Activity of Rubratin. Results of a Phase II Trial in Advanced Lung Cancer

Experience with the Polyelectrolyte Carbetimer in Early Clinical Trials1

Trimetrexate: An Update of Recent Basic and Clinical Results

Subject Index

In vivo Modulation of the Immune System by Mafosfamide in Patients with Advanced Renal Cell Carcinoma. A Phase I Trial

Treatment of Patients with Chronic Lymphocytic Leukemia and Non-Hodgkin’s Lymphoma of Low-Grade Malignancy with 1,2,4-Triglycidylurazol

Intensive-Dose Epirubicin with and without High-Dose Verapamil: Toxicity, Pharmacokinetics, Metabolism and Response in Pretreated Patients with Metastatic Breast Cancer

Phase II Study of High-Dose Epirubicin in Non-Small Cell Lung Cancer

Phase II Study of Pirarubicin in Small Cell Lung Carcinoma

Contributions to Oncology - New Drugs in Oncology
Latest Publications